Hypoxia inducible factor-1 mediates pancreatic β-cell dysfunction by intermittent hypoxia

Obstructive sleep apnea and incident type 2 diabetes

(2016) Mako Nagayoshi et al.   SLEEP MEDICINE

Intermittent hypoxia is an independent marker of poorer glycaemic control in patients with uncontrolled type 2 diabetes

(2015) M. Torrella et al.   DIABETES & METABOLISM

HIF-1α Activation by Intermittent Hypoxia Requires NADPH Oxidase Stimulation by Xanthine Oxidase

(2015) Jayasri Nanduri et al.   PLoS One

Regulation of hypoxia-inducible factor-α isoforms and redox state by carotid body neural activity in rats

(2014) Ying-Jie Peng et al.   JOURNAL OF PHYSIOLOGY-LONDON

Impairment of pancreatic β-cell function by chronic intermittent hypoxia

(2013) Ning Wang et al.   EXPERIMENTAL PHYSIOLOGY

Hypoxia-Inducible Factors in Physiology and Medicine

(2012) Gregg L. Semenza   CELL

The E-loop Is Involved in Hydrogen Peroxide Formation by the NADPH Oxidase Nox4

(2011) Ina Takac et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The NADPH Oxidase Subunit NOX4 Is a New Target Gene of the Hypoxia-inducible Factor-1

(2010) Isabel Diebold et al.   MOLECULAR BIOLOGY OF THE CELL

Induction of HIF-1α expression by intermittent hypoxia: Involvement of NADPH oxidase, Ca2+signaling, prolyl hydroxylases, and mTOR

(2008) Guoxiang Yuan et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Digoxin and other cardiac glycosides inhibit HIF-1  synthesis and block tumor growth

(2008) H. Zhang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA